CellFE launches T-Rest™, a first-in-class testing T cell kit for the manufacture of safer, more durable cell therapies. As part of the launch, CellFE has released an application note on its non-viral, ...

Modifying T cells before activation and expanding them in vitro may lead to more effective and safer immunotherapy treatments. If the challenges associated with resting T cell transfection can be ...

A team of immunologists at the University of Massachusetts Amherst has turned what we know about T-cells, one of the most important parts of the body's immune system, on its head, opening the door to ...

A hidden “jack-in-the-box” mechanism inside T cells may hold the key to unlocking more powerful cancer immunotherapies.

Scientists have discovered that T cell receptors activate through a hidden spring-like motion that had never been seen before ...

Pre-wired ability in ‘resting’ T cells to remember past viral foes discovered, a promising breakthrough for targeted cancer therapies. A team of immunologists at the University of Massachusetts ...

Researchers at the Johns Hopkins Kimmel Cancer Center’s Ludwig Center developed a new treatment that selectively targets ...

Cytotoxic T cells are star players in the adaptive immune system, enforcing protection against invading viruses or cancer cells. However, evidence has been mounting that the cells may also deal a ...

One of the most exciting advances in cancer treatments in the past decade is the development of T cell immunotherapies, in which a patient's own immune system is trained to recognize and attack ...